Table 2.
Galactosylated-chitosan nanoparticles designed for the treatment of HCC and liver-targeting: the therapeutic/theranostic effect and cell cultures used in the study are reported for each reference.
| Carrier | Payload | Effect | Cell Culture | Reference |
|---|---|---|---|---|
| Galactosylated chitosan | plasmid DNA | anti-cancer gene delivery |
HepG2 | [69] |
| Galactosylated chitosan | 5-fluorouracil | anti-cancer | - | [70,71,72] |
| Galactosylated chitosan | adenosine triphosphate | anti-cancer | HepG2 | [73] |
| Galactosylated chitosan–polycaprolactone | curcumin | anti-cancer anti-oxidant |
HepG2 | [74,75] |
| Galactosylated-carboxymethyl chitosan | magnetic iron oxide | theranostics | - | [76] |
| Galactosylated chitosan | triptolide | anti-cancer anti-inflammatory |
- | [77] |
| Galactosylated chitosan | gemcitabine | anti-cancer antimetabolite |
- | [78] |